Calliditas Therapeutics AB American Depositary Shares
CALT
CALT was delisted on the 20th of September, 2024.
0 hedge funds and large institutions have $0 invested in Calliditas Therapeutics AB American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $750K → $0 (-$750K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
-$655K |
| 2 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$81.5K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$12.2K |
| 4 |
MTIC
Missouri Trust & Investment Company
Springfield,
Missouri
|
-$1.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CGH
1
Crossmark Global Holdings
Houston,
Texas
| – | -$655K | -16,117 | Closed |
|
|
AP
2
Advisors Preferred
Rockville,
Maryland
| – | -$81.5K | -2,022 | Closed |
|
|
3
RhumbLine Advisers
Boston,
Massachusetts
| – | -$12.2K | -303 | Closed |
|
|
MTIC
4
Missouri Trust & Investment Company
Springfield,
Missouri
| – | -$1.4K | -35 | Closed |
|
CALT Hedge Fund Activity: Q4 2024 in Review
0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q4 2024, worth a combined $0 — down 100% from $750K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CALT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Crossmark Global Holdings, exiting entirely with an estimated $655K sold.
- 0 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q4 2024, down from 5 in Q3 2024.
- Funds reported $0 of Calliditas Therapeutics AB American Depositary Shares stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q4 2024 and 5 closed out, a net change of -5 holders.
- The largest Calliditas Therapeutics AB American Depositary Shares seller in Q4 2024 was Crossmark Global Holdings, an estimated $655K sold.
Based on aggregated 13F filings for Q4 2024.